Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0MU9L
|
||||
| Former ID |
DCL000166
|
||||
| Drug Name |
Migalastat
|
||||
| Synonyms |
DDIG; D-Galactitol, 1,5-dideoxy-1,5-imino; (2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol; 1,5-Dideoxy-1,5-iminogalactitol; 2-(Hydroxymethyl)-3,4,5-piperidinetriol hydrochloride
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Fabry's disease [ICD9: 272.7; ICD10:E75.2] | Preregistration | [1] | ||
| Company |
Amicus Therape.
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C6H13NO4
|
||||
| Canonical SMILES |
C1C(C(C(C(N1)CO)O)O)O
|
||||
| InChI |
1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5+,6-/m1/s1
|
||||
| InChIKey |
LXBIFEVIBLOUGU-DPYQTVNSSA-N
|
||||
| CAS Number |
CAS 167933-07-5
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
796556, 10258334, 11114003, 15066543, 15321768, 33499767, 34884209, 50069796, 76308781, 103329495, 104049440, 104425300, 128553861, 131271591, 131481001, 131481032, 134348144, 135154287, 137263801, 139879276, 144203290, 144221323, 162774201, 172232452, 178483437, 198184004, 198975997, 223733290, 227686116, 249807450, 250135145
|
||||
| Target and Pathway | |||||
| Target(s) | Alpha-galactosidase A | Target Info | Modulator | [2], [3] | |
| KEGG Pathway | Galactose metabolism | ||||
| Glycerolipid metabolism | |||||
| Sphingolipid metabolism | |||||
| Glycosphingolipid biosynthesis - globo series | |||||
| Lysosome | |||||
| PathWhiz Pathway | Sphingolipid Metabolism | ||||
| Galactose Metabolism | |||||
| Reactome | Glycosphingolipid metabolism | ||||
| WikiPathways | Sphingolipid metabolism | ||||
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019652) | ||||
| REF 2 | AT-1001: a high-affinity alpha3beta4 nAChR ligand with novel nicotine-suppressive pharmacology. Br J Pharmacol. 2015 Apr;172(7):1834-45. | ||||
| REF 3 | The pharmacological chaperone 1-deoxygalactonojirimycin increases alpha-galactosidase A levels in Fabry patient cell lines. J Inherit Metab Dis. 2009 Jun;32(3):424-40. Epub 2009 Apr 18. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.